Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Scott

Showing results (91-100 of 461) with videos related to

Pageof 47
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2011
Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosisMathew B Cox, Maria Ban, Nikola A Bowden, et al.
Oncotarget|August 12, 2021
Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutionsRodney J Scott, Anurag Mehta, Gabriel S Macedo, et al.
Plos One|September 13, 2012
MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1Kyu-Tae Kim, Adam P Carroll, Baratali Mashkani, et al.
Diabetes Care|July 28, 2004
Phenotype-genotype correlations in a series of wolfram syndrome familiesCasey J A Smith, Patricia A Crock, Bruce R King, et al.
Hereditary Cancer in Clinical Practice|December 5, 2012
DNA and RNA analyses in detection of genetic predisposition to cancerGrzegorz Kurzawski, Dagmara Dymerska, Pablo Serrano-Fernández, et al.
International Journal of Endocrinology|October 13, 2015
Methylation of the Corticotropin Releasing Hormone Gene Promoter in BeWo Cells: Relationship to Gene ActivityXin Pan, Maria Bowman, Rodney J Scott, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology?Kira Groen, Vicki E Maltby, Katherine A Sanders, et al.
BMC Cancer|July 22, 2010
Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer riskKatie A Ashton, Anthony Proietto, Geoffrey Otton, et al.
Hereditary Cancer in Clinical Practice|August 2, 2018
CD36 - a plausible modifier of disease phenotype in familial adenomatous polyposisMerran Holmes, Toni Connor, Christopher Oldmeadow, et al.
Cancer Epidemiology|August 15, 2009
Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphismJózef Kładny, Janina Suchy, Ewa Kłujszo-Grabowska, et al.
Pageof 47

Showing results (91-100 of 461) with videos related to

Sort By:
Pageof 47
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 6, 2011
Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosisMathew B Cox, Maria Ban, Nikola A Bowden, et al.
Oncotarget|August 12, 2021
Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutionsRodney J Scott, Anurag Mehta, Gabriel S Macedo, et al.
Plos One|September 13, 2012
MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1Kyu-Tae Kim, Adam P Carroll, Baratali Mashkani, et al.
Diabetes Care|July 28, 2004
Phenotype-genotype correlations in a series of wolfram syndrome familiesCasey J A Smith, Patricia A Crock, Bruce R King, et al.
Hereditary Cancer in Clinical Practice|December 5, 2012
DNA and RNA analyses in detection of genetic predisposition to cancerGrzegorz Kurzawski, Dagmara Dymerska, Pablo Serrano-Fernández, et al.
International Journal of Endocrinology|October 13, 2015
Methylation of the Corticotropin Releasing Hormone Gene Promoter in BeWo Cells: Relationship to Gene ActivityXin Pan, Maria Bowman, Rodney J Scott, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology?Kira Groen, Vicki E Maltby, Katherine A Sanders, et al.
BMC Cancer|July 22, 2010
Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer riskKatie A Ashton, Anthony Proietto, Geoffrey Otton, et al.
Hereditary Cancer in Clinical Practice|August 2, 2018
CD36 - a plausible modifier of disease phenotype in familial adenomatous polyposisMerran Holmes, Toni Connor, Christopher Oldmeadow, et al.
Cancer Epidemiology|August 15, 2009
Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphismJózef Kładny, Janina Suchy, Ewa Kłujszo-Grabowska, et al.
Pageof 47